PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
16-Dec-2025 President Trump Cleaning Up Biden's Marijuana Mess - MMJ Preparing to Move FDA Huntington's Cannabis Trials Forward ACCESS Newswire
15-Dec-2025 Healthcare Payer IT in 2026: Digital Prior Authorization, Enforceable Transparency, and Outcomes-Driven Platforms Spark a New Acquisition Race ACCESS Newswire
15-Dec-2025 New National Alliance Launches to Address Health Workforce Shortages in Underserved Communities ACCESS Newswire
15-Dec-2025 Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million ACCESS Newswire
15-Dec-2025 Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages ACCESS Newswire
15-Dec-2025 Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF) ACCESS Newswire
15-Dec-2025 IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines ACCESS Newswire
15-Dec-2025 Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults ACCESS Newswire
15-Dec-2025 EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA) ACCESS Newswire
15-Dec-2025 Amphastar Announces FDA Approval for Teriparatide Injection ACCESS Newswire
15-Dec-2025 Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out ACCESS Newswire
15-Dec-2025 Biovica Signs Client Bill Agreement with Leading U.S. NCI-Designated Cancer Center ACCESS Newswire
15-Dec-2025 Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics ACCESS Newswire
13-Dec-2025 President Trump's Cannabis Decision Is Coming - And Why MMJ International Holdings Wins Either Way ACCESS Newswire
12-Dec-2025 Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care ACCESS Newswire
12-Dec-2025 Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements ACCESS Newswire
12-Dec-2025 VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 ACCESS Newswire
12-Dec-2025 Cadrenal's Quiet Expansion Play Is Starting to Get Loud ACCESS Newswire
12-Dec-2025 Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market ACCESS Newswire
12-Dec-2025 VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement ACCESS Newswire